期刊文献+

小鼠α1,2岩藻糖基转移酶基因的克隆及表达 被引量:1

CLONING AND EXPRESSION OF MURINE α1,2-FUCOSYLTRANSFERASE GENE
下载PDF
导出
摘要 本文报告小鼠GDP岩藻糖:β半乳糖苷α1,2-岩藻糖基转移酶(α1,2-fucosyltansferase,α1,2- FT)基因的克隆,并进行功能鉴定。利用RT-PCR方法克隆小鼠α1,2-岩藻糖基转移酶基因编码区 MFUT-Ⅱ,测序后将其插入表达载体pcDNA3.1的多克隆位点,构建表达载体pcDNA3.1-MFUT-Ⅱ; 采用磷酸钙法将其转染于COS-7细胞进行表达,通过对底物特异性比较研究酶的性质;应用 Northern印迹杂交法研究基因在小鼠组织中的表达情况;应用southern印迹杂交法分析基因存在状态。结果证实MFUT-Ⅱ为小鼠α1,2-岩藻糖基转移酶基因家族的新成员,含有一个完整的开放读码框,可编码347个氨基酸.其估计分子质量为39 kDa,和小鼠H及Secl基因具有序列同源性,分别与人类Se基因(79.0%)、大鼠Rat FTB(89%)基因、兔Rabbit FT-Ⅲ基因(77%)具有较高的序列同源性。用MFUT-Ⅱ基因转染的COS-7细胞具有α1,2-FT活性,MFUT-Ⅱ可在多种组织中产生 3.5kb大小的mRNA转录产物。基因Southern印迹杂交分析结果显示:基因MFUT-Ⅱ仅为一个拷贝。这些结果证明MFUT-Ⅱ为小鼠的Se基因。 MFUT-II, a DNA fragment encoding murine α1,2-fucosyhransferase,was cloned by RT-PCR. The open-reading frame was ligated into mammalian expression vector pcDNA 3.1 (pcDNA3.1-MFUT-11 ) and was transiently transfected into COS-7 cells using a Cellphect Transfection kit. Moreover, the expression of the gene in murine tissues was analyzed with Northern hybridization showing a 3.5-Kb mRNA transcript product in several tissues. The existence of MFUT-Ⅱ was detected by Southern blot. MFUT-Ⅱ was found to be a new member of the murine α1,2-FT gene family. Its open reading frame encoded 347 amino acids with a predicted molecular mass of 39.21 kDa and exhibited sequence homology with murine H & Secl gene. MFUT-Ⅱ also exhibited sequence homology with Human Se gene (79.0%), Rat FTB gene (89.0%) and Rabbit FT-Ⅲ gene (77.0%), respectively. COS-7 cells transfected with pcDNA3.1-MFUT-11 showed alpha 1,2-fucosyhransferase activity. Southern analysis revealed that MFUT-Ⅱ was present in the mouse genome as a single-copy gene. In conclusion, MFUT-Ⅱ was a murine Se gene.
出处 《实验生物学报》 CSCD 北大核心 2005年第6期536-544,共9页 Acta Biologiae Experimentalis Sinica
关键词 α1 2-岩藻糖基转移酶 基因 克隆 表达 小鼠 α1,2-fucosyltransferase. Gene. Clone. Expression. Mice.
  • 相关文献

参考文献10

  • 1Yazawa, S., T. Nishimura, M. Ide, T. Asao, A. Okamura, S.Tanaka, I, Takai, Y. Yagihashi, AR. Saniabadi & N.Kochibe, 2002, Tumor-related expression of alpha 1,2fucosylated antigens on colorectal carcinoma cells and its suppression by cell-mediated priming using sugar acceptors for alphal,2 fucosyhransferase. Glycobiology, 12(9):545-553.
  • 2Sun, J., J. Thurin, HS. Cooper, P. Wang, M. Mackiewicz,Z. Steplewski & M. Blaszczyk-Thurin, 1995, Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc. Natl. A cad. Sci.USA. 92(12): 5724-5728.
  • 3Bry, L., PG. Falk, T. Midtvedt &JI.Gordon, 1996,A model of host-microbial interactions in an open mammalian ecosystem. Science, 273(5280): 1380-1383.
  • 4Larsen, R.D., L.K. Ernst, R.P. Nair & J.B.Lowe, 1990,Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside -alpha-L- fucosyl-transferase cDNA that can form the H blood group antigen. Proc. Natl. Acad. Sci. USA, 87(17): 6674-6678.
  • 5Koda, Y., M. Soejima, B. Wang & H. Kimura, 1997,Structure and expression of the gene encoding secretor-type galactoside 2-alpha-L-fucosyltransferase (FUT2).Eur. J. Biochem, 246 (3): 750-755 .
  • 6Bureau, V., S. Marionneau, A. Cailleau-Thomas, B. Le Moullac-Vaidye, T. Liehr, & J. Le Pendu , 2001, Comparison of the three rat GDP-L-fucose:beta-D-galactoside2-alpha-L- fucosyltransferases FTA, FTB and FTC. Eur. J.Biochem., 268 (4): 1006-1019.
  • 7Hitoshi, S., S. Kusunoki, I. Kanazawa & S.Tsuji, 1996,Molecular cloning and expression of a third type of rabbit GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyl-transferase. J. Biol. Chem., 271 (28): 16975-16981.
  • 8Ernst, L .K., V.P. Rajan, R.D. Larsen, M.M. Ruff & J.B.Lowe 1989, Stable expression of blood group H determinants and GDP-L-fucose: beta-D-galactoside 2-alpha-L-fucosyhransferase in mouse cells after transfection with human DNA. J Biol Chem., 264(6): 3436-3447.
  • 9Iwamori, M., & SE. Domino, 2004, Tissue-specific loss of fucosylated glycolipids in mice with targeted deletion of alpha(1,2)fucosyltransferase genes. Biochem J., 380: 75-81.
  • 10Lin, B., Y. Hayashi, Mo Saito, Yo Sakakibara, M, Yanagisawa & M. Iwamori, 2000, GDP-fucose: beta-galactoside alphal,2-fucosyhransferase, MFUT-Ⅱ, and not MFUT-Ⅰ or-Ⅲ, is induced in a restricted region of the digestive tract of germ-free mice by host-microbe interactions and cycloheximide. Biochim Biophys Acta., 1487(2-3): 275-285.

同被引文献17

  • 1Liu F, Qi HL & Chen HL, Regulation of differentiationand prolifertion-inducers on Lewis antigens, alpha-fucosyhransferase and metastatic potential in hepatocarcinoma cells. Br J Cancer, 2001 ; 84(11) : 1 556-1 563.
  • 2Inufusa H, Adachi T, Kiyokawa T, Nakatani Y, Wakano T, Nakamura M, Okuno K, Shiozaki H, Yamamoto S, Suzuki M, Ando O, Kurimoto M, Miyake M & Yasutomi M, Ley glycolipid-recognizing monoclonal antibody inhibits procoagulant activity and metastasis of human adenocarcinoma. Int J Oncol, 2001, 19(5) : 941-946.
  • 3Scott AM, Geleick D, Rubira M, Clarke K, Nice EC, Smyth FE, Stockert E, Richards EC, Carr FL, Harris WJ, Armour KL, Rood J, Kypridis A, Kronina V, Murphy R, Lee Fr, Liu Z, Kitamura K, Rittter G, Laughton K, Hoffman E, Burgess AW & Old I J, Construction, production, and characterization of humanized anti-Lewis y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors. Cancer Research, 2000, 60(15): 3 254-3 261.
  • 4Sabbatini PJ, Kudryashov V, Ragupathi G, Danishefsky S J, Livingston PO, Bornmann W, spassova M, Zatorski A, Spriggs D, Aghajanian C, Soignet S, Pevton M, O'Flaherty CC, Curtin J & Lloyd KO, Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial. Int J Cancer, 2000, 87(1): 79-85.
  • 5Halloran MM, Carley WW, Polverini PJ, Haskell C J, Phan S, Anderson B J, Woods JM, Campbell PL, Volin MV, Backer AE & Koch AE, Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol, 2000, 164(9): 4 868-4 877.
  • 6Basu A, Murthy U, Rodeck U, Herlyn M, Mattes L & Das M, Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. CancerRes, 1987, 47(10): 2 531-2 536.
  • 7Federici MF, Kudryashov V, Saigo PE, Finstad CL & Llovd KO, Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int J Cancer, 1999, 81(2) : 193-198.
  • 8Lin B, Hayashi Y, Saito M, Sakakibara Y, Yanagisawa M & lwamori M, GDP-fucose: beta-galactoside alphal, 2-fucosyhransferase, MFUT-Ⅱ, and notMFUT-Ⅱ or -Ⅲ, is induced in a restricted region of the digestive tract of germ-free mice by host-microbe interactions and cycloheximide. Biochem Biophys Acta, 2000, 1487 (2-3): 275-285.
  • 9Nakagoe T, Fukushmia K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, Ayabe H, Hara S, Ishikawa H & Minami H, Expression of ABH, Lewis-related antigens as prognostic factors in patients with breast cancer. J Cancer Res Clin Oncol, 2002, 128(5): 257-264.
  • 10Nakagoe T, Fukushima K, Nanashima A, Sawai T, Tsuji T, Jibiki M, Yamaguchi H, Yasutake T, Ayabe H, Matuo T, Tagawa Y & Arisawa K, Expression of Lewis (a) , sialyl Lewis (a) , Lewis (x) , and sialyl Lewis (x) antigens as prognostic factors in patients with colorectal cancer. Can J Gastroenterol, 2000, 14(9): 753-760.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部